RSS
John Johnson
Asking the right questions when regulations are revised in sterile manufacturing
In this article, John Johnson, vice president, Pharma Biotech, NSF International, looks at the revision to Annex 1 and the important questions steriles manufacturers and pharma suppliers should be asking themselves. Read more